Article Impact Level: HIGH Data Quality: STRONG Summary of Cell Communication and Signaling https://doi.org/10.1186/s12964-026-03247-7 Dr. Lindsay Grace Miller et al.
Points
- Washington State University researchers investigated cellular signaling mechanisms to determine how extracellular ISG15 proteins function as natural boosters to protect surrounding tissue against invading viral pathogens.
- Scientific analyses revealed that extracellular ISG15 engages cell surface integrins through an RGD-like motif to activate downstream integrin-FAK signaling pathways within epithelial cells.
- This newly identified non-canonical defense mechanism operates independently of traditional interferon-driven responses by stabilizing basal intracellular ISG15 protein levels to support enhanced cellular ISGylation.
- Experimental validation demonstrated that artificially amplifying this pathway significantly increased host cell resistance against respiratory syncytial virus, influenza A, and various other respiratory pathogens.
- Authors concluded that targeting host cell mechanisms rather than mutating viral proteins offers a promising therapeutic strategy applicable to infectious diseases, oncology, and neurological disorders.
Summary
This study evaluated an alternative, non-canonical antiviral defense mechanism mediated by extracellular ISG15 in epithelial cells. Published in Cell Communication and Signaling by researchers at Washington State University, the investigation addressed the limitations of traditional direct-acting antiviral drugs that frequently fail due to rapid viral mutation. Given that host cells possess intrinsic defense systems that are often only weakly activated during initial pathogen exposure, the research sought to identify cellular signaling pathways that can be artificially amplified to enhance broad-spectrum cellular resistance.
The experimental findings revealed that extracellular ISG15 functions as a soluble antiviral factor that triggers an interferon-independent ISGylation response. Specifically, extracellular ISG15 engages cell surface integrins via an RGD-like motif to activate the integrin-FAK signaling pathway. In the absence of transcriptional upregulation, this signaling cascade enhances the post-translational stability of basal intracellular ISG15 proteins, thereby supporting robust cellular ISGylation. Through this non-canonical mechanism, amplifying extracellular ISG15 significantly restricted infection by respiratory syncytial virus (RSV), influenza A, and parainfluenza viruses in epithelial cells.
The authors conclude that boosting host cell defenses via extracellular ISG15-mediated integrin-FAK signaling offers a highly effective host-directed therapeutic strategy. Because this mechanism strengthens the host’s own cellular machinery rather than targeting viral proteins, it remains resilient against viral mutations. Furthermore, because the pathway stimulates critical cellular processes, it holds significant therapeutic potential beyond infectious diseases for applications in oncology and neurological disorders.
Link to the article: https://link.springer.com/article/10.1186/s12964-026-03247-7
References
Miller, L. G., Chiok, K. L. R., Pandit, S., Mariasoosai, C., Mohanty, I., Deol, P., Mehari, L., Teng, M. N., Hoffman, M. A., Remiker, S. E., Haas, A. L., Natesan, S., Miura, T. A., & Bose, S. (2026). Integrin-FAK signaling dependent non-canonical ISGylation by extracellular ISG15 restricts human respiratory syncytial virus infection in epithelial cells. Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03247-7
